Evidence map›Paper›PMID 42371051›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2026

Post-COVID: a specific neuropsychological profile in performance deficits.

Britta Müller, Ulrike Balz, Katharina Bartels, Farina Eggers, Micha Löbermann, Luise Nostitz, Juliane Schmidt, Carola Schwarz, Christine Wossidlo, Emil C Reisinger and 1 more

Abstract read
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Britta MüllerInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Ulrike BalzInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Katharina BartelsInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Farina EggersInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Micha LöbermannDivision of Tropical Medicine and Infectious Diseases, Department of Internal Medicine II, Rostock University Medical Center, Rostock, Germany.
Luise NostitzInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Juliane SchmidtInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Carola SchwarzInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany.
Christine WossidloDivision of Tropical Medicine and Infectious Diseases, Department of Internal Medicine II, Rostock University Medical Center, Rostock, Germany.
Emil C ReisingerDivision of Tropical Medicine and Infectious Diseases, Department of Internal Medicine II, Rostock University Medical Center, Rostock, Germany.
Peter KroppInstitute of Medical Psychology and Medical Sociology, Rostock University Medical Centre, Rostock, Germany. peter.kropp@med.uni-rostock.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2 is frequently associated with cognitive impairment. When symptoms persist for more than four weeks after acute infection, a Long-COVID condition is diagnosed. When persisting more than 12 weeks, Post-COVID ist diagnosed. Cognitive complaints commonly include impairments in attention, memory, and executive functions. However, precise data on the specific pattern and extent of these deficits remain limited.

methodsResults: Conclusions: The findings indicate that attentional impairments are more prevalent than memory deficits in this Post-COVID cohort. Furthermore, distinct cognitive profiles can be identified using cluster analysis, ranging from globally impaired to cognitively preserved subgroups. These results may be relevant for clinical characterization and rehabilitation planning in Post-COVID conditions.

methodsWe examined 88 patients (mean age 50.9 years, 80.7% female) diagnosed with COVID symptoms according to the WHO-criteria. Neuropsychological assessment was performed using a standardized test battery covering attentional performance, working memory, and executive functions. A cluster analysis was conducted to identify subgroups based on cognitive performance profiles.

resultsOverall, 55.7% of patients showed below-average attentional performance, whereas memory deficits were less frequent (33.0%). Impairments in executive functions were similarly distributed across the sample. Cluster analysis yielded a three-cluster solution. Cluster 1 (34.1%) was characterized by pronounced impairments across all cognitive domains. Cluster 2 (20.0%) showed generally below-average cognitive performance; however, verbal fluency was preserved at or above average in all participants. In Cluster 3 (17.6%) more than 50% of patients in performed within average to above-average ranges across all cognitive domains.

conclusionsThe findings indicate that attentional impairments are more prevalent than memory deficits in this Post-COVID cohort. Furthermore, distinct cognitive profiles can be identified using cluster analysis, ranging from globally impaired to cognitively preserved subgroups. These results may be relevant for clinical characterization and rehabilitation planning in Post-COVID conditions.

Indexed as

Cognitive DysfunctionCOVID-19Executive FunctionMemory DisordersAdultAgedAttentionCognition DisordersFemaleHumansMaleMemory, Short-TermMiddle AgedNeuropsychological TestsPost-Acute COVID-19 SyndromeAttentionMemoryMoodPost COVIDWxecutive functions

Identifiers

PMID42371051
PMCPMC13687127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.